share_log

Turning Point Therapeutics | SC14D9C: Written communication by the subject company relating to a third party tender offer

Turning Point Therapeutics | SC14D9C:報價書面通信

2022/06/03 09:05
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息